ArticleCommunications medicine2026

Bacillus Calmette-Guérin (BCG) immunotherapy reprograms CNS immunity and alters Alzheimer's biomarkers: results from two open-label clinical trials.

Marc S Weinberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.